This Cannabis Biotech Stock Popped Higher On
Its CBD Oil Drug
More
GW Pharmaceuticals stock
jumped 10% early Wednesday on its strong launch for cannabinoid oil
Epidiolex in seizure treatment. Epidiolex generated $4.7 million in
sales over two months.